Company Filing History:
2 out of 1,384 
1 out of 13 
1 out of 832,891 Years Active: 2001-2002
Title: Pál Berzsenyi: Innovator in Medicinal Chemistry
Introduction
Pál Berzsenyi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the central nervous system. With a total of 4 patents to his name, Berzsenyi's work has implications for treating various neurological disorders.
Latest Patents
Among his latest patents are innovative compounds related to 2,3-benzodiazepine derivatives. These include condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors. The invention concerns compounds of formula (I), where R, R, R, and R can represent hydrogen or various substituents; X can be hydrogen or halogen; Y can be C1-alkoxy or a combination of X and Y that forms a specific structure. The compounds are designed to non-competitively inhibit AMPA receptors, making them potential medicaments for treating diseases of the central nervous system.
Career Highlights
Throughout his career, Pál Berzsenyi has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Gyogyszerkutato Intezet Kft. His expertise in medicinal chemistry has allowed him to contribute to the development of important therapeutic agents.
Collaborations
Some of his notable coworkers include Antal Simay and István Ling. Their collaborative efforts have further advanced the research and development of innovative medicinal compounds.
Conclusion
Pál Berzsenyi's contributions to medicinal chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of treatments for central nervous system diseases.